Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Confidence
Digital care
Antiviral agents
Vaccine safety and efficacy
COVID-19
Antiretroviral therapy
Vaccine hesitancy
Antiviral therapy
Adverse effects
Clinical practice
Adjuvant
Deletion
Vaccine effectiveness
Chronic kidney disease
Determinant
Cohort study
ANTIRETROVIRAL THERAPY
EHealth literacy
Antiviral
Digital health intervention
Drug
Awareness
B-lymphocytes
Efficacy
Vaccination
Conditional marketing authorization
Vaccine
Innate immunity
Influenza
Acute kidney injury
Diabetes mellitus type 2
Covid 19
Catch-up
Adults
Assay
Dialysis
Attitudes
Conjugate pneumococcal vaccine
Effectiveness
COCONEL cohort surveys
Influenza-like illness
Determinants
Immunocompromised
Vaccine acceptance
Dendritic cells
EMA
Elderly
Delphi study
Covidom
Sleep
Respiratory syncytial virus
Cystic fibrosis
Clinical trials
AstraZeneca vaccine
Misinformation
CERVICOVAGINAL SECRETIONS
Cohort
Cancer
AON
Immunogenicity
Cost of illness
Incidence
Boys
France
C-type lectin receptor
Covid-19
Coadministration
Disinformation
Déterminants
COVID-19 vaccines
Dose escalation
Data sharing
Adenoviral vector
AIDS
Vaccines
Attitude
Calcium phosphorus evaluation
Co-morbidities
Coronavirus
Alpha variant
Clinical skills
Internet
HIV
Booster response
1790GAHB F
Risk factors
Chemotherapy
Hesitancy
DMD
SARS-CoV-2
HPV vaccine
Biomarkers
Practices
Epidemiology
Care management
Immunization
Healthcare workers
Clinical research
Attitude to health
Attitudes of health personnel